ATE227127T1 - Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes - Google Patents

Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes

Info

Publication number
ATE227127T1
ATE227127T1 AT96915595T AT96915595T ATE227127T1 AT E227127 T1 ATE227127 T1 AT E227127T1 AT 96915595 T AT96915595 T AT 96915595T AT 96915595 T AT96915595 T AT 96915595T AT E227127 T1 ATE227127 T1 AT E227127T1
Authority
AT
Austria
Prior art keywords
tripicolinate
chrome
diabetes
treatment
type
Prior art date
Application number
AT96915595T
Other languages
English (en)
Inventor
Mark F Mccarty
Original Assignee
Nutrition 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 filed Critical Nutrition 21
Application granted granted Critical
Publication of ATE227127T1 publication Critical patent/ATE227127T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96915595T 1995-05-12 1996-05-08 Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes ATE227127T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/440,362 US6329361B1 (en) 1995-05-12 1995-05-12 High-dose chromic picolinate treatment of type II diabetes
PCT/US1996/006493 WO1996035421A1 (en) 1995-05-12 1996-05-08 High-dose chromic tripicolinate for the treatment of type ii diabetes

Publications (1)

Publication Number Publication Date
ATE227127T1 true ATE227127T1 (de) 2002-11-15

Family

ID=23748461

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915595T ATE227127T1 (de) 1995-05-12 1996-05-08 Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes

Country Status (15)

Country Link
US (1) US6329361B1 (de)
EP (1) EP0825861B1 (de)
JP (1) JP3699124B2 (de)
AR (1) AR004486A1 (de)
AT (1) ATE227127T1 (de)
AU (1) AU5733796A (de)
BR (1) BR9608835A (de)
DE (1) DE69624699T2 (de)
DK (1) DK0825861T3 (de)
ES (1) ES2183952T3 (de)
IL (1) IL118222A (de)
PT (1) PT825861E (de)
RU (1) RU2195934C2 (de)
WO (1) WO1996035421A1 (de)
ZA (1) ZA963735B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
AU751431B2 (en) * 1997-08-08 2002-08-15 Nutrition 21 Chromium/biotin treatment of type II diabetes
EP0925790A1 (de) * 1997-12-17 1999-06-30 Kartar Dr. Lalvani Vitamin- und Mineralzusammensetzungen zum Behandlung von X-Syndrom oder Insulin-unabhängigem Diabetes Mellitus
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
US5948772A (en) 1998-08-28 1999-09-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US6143301A (en) * 1998-08-28 2000-11-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US5905075A (en) * 1998-08-28 1999-05-18 Ambi Inc. Chromium nicotinate compositions and uses thereof
US6852760B1 (en) 1998-09-17 2005-02-08 Akesis Pharmaceuticals, Inc. Compositions and methods for treatment for glucose metabolism disorders
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
CN1665566A (zh) 2000-09-21 2005-09-07 营养21公司 用铬络合物、共轭脂肪酸和 /或共轭脂肪醇治疗糖尿病、减少身体脂肪、改善胰岛素敏感性、缓解高血糖症和高胆固醇血症的方法和组合物
AU2003226313A1 (en) * 2002-04-23 2003-11-10 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
CN100457122C (zh) * 2002-05-14 2009-02-04 尼普洛株式会社 包含三价铬离子的化合物在制备用于预防和/或治疗淀粉样变性的药物的应用
US6831077B2 (en) * 2002-07-25 2004-12-14 Comprehensive Neuroscience, Inc. Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation
US20050019435A1 (en) * 2003-07-21 2005-01-27 Jeffrey Young Method of treating non-insulin dependent diabetes mellitus and related complications
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
EP2120930A4 (de) * 2007-01-31 2012-12-05 Nutrition 21 Inc Verwendung von chromhistidinat zur behandlung von kardiometabolischen erkrankungen
EP3050568B1 (de) 2007-03-13 2020-12-02 JDS Therapeutics, LLC Verfahren und zusammensetzungen zur verzögerten freisetzung von chrom
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP3513790A1 (de) 2009-07-01 2019-07-24 JDS Therapeutics, LLC Chromkomplexe als enhancer von glucosetransportern im hirn
ES2927800T3 (es) 2011-03-01 2022-11-11 Nutrition 21 Llc Composición de insulina y cromo para el tratamiento y la prevención de diabetes, hipoglicemia y trastornos relacionados
CN107404902A (zh) 2015-02-13 2017-11-28 马斯公司 宠物食物饲喂系统
GB2564295A (en) 2016-02-11 2019-01-09 Nutrition 21 Llc Chromium containing compositions for improving health and fitness
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315927A (en) * 1980-08-08 1982-02-16 The United States Of America As Represented By The Secretary Of Agriculture Dietary supplementation with essential metal picolinates
US5087623A (en) * 1988-05-31 1992-02-11 Nitrition 21 Chromic picolinate treatment
US5164384A (en) 1991-06-19 1992-11-17 Metagenics, Inc. Anabolic mineral formula

Also Published As

Publication number Publication date
MX9708628A (es) 1998-06-28
AU5733796A (en) 1996-11-29
BR9608835A (pt) 1999-12-07
ZA963735B (en) 1997-01-09
WO1996035421A1 (en) 1996-11-14
DE69624699T2 (de) 2003-03-20
IL118222A0 (en) 1996-09-12
AR004486A1 (es) 1998-12-16
JP3699124B2 (ja) 2005-09-28
IL118222A (en) 2000-06-01
DE69624699D1 (de) 2002-12-12
EP0825861A1 (de) 1998-03-04
DK0825861T3 (da) 2003-03-03
EP0825861B1 (de) 2002-11-06
US6329361B1 (en) 2001-12-11
ES2183952T3 (es) 2003-04-01
PT825861E (pt) 2003-03-31
JPH11504941A (ja) 1999-05-11
RU2195934C2 (ru) 2003-01-10

Similar Documents

Publication Publication Date Title
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE122007000002I1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes.
DE69817446D1 (de) Behandlung von diabetes
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69612649T2 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69427869T2 (de) Botulinumtoxine zur behandlung von hyperhydrosis
ATE235236T1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE69307509T2 (de) Vorrichtung zur behandlung von herzfehlern
DE69804659T2 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE69527140D1 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69426848D1 (de) Gerät zur Behandlung von lichtempfindlichen Materialien
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE990441T1 (de) Arzneimittel zur behandlung von diabetischer nephrosis
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE69412178T2 (de) Apparat zur Behandlung von Lagen
DE69806062D1 (de) Kombinationstherapie zur behandlung von aids
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69306260T2 (de) Behandlung von abwasser
DE59911556D1 (de) Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor
ATA93695A (de) Mittel zur behandlung von strahlenschäden
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0825861

Country of ref document: EP

REN Ceased due to non-payment of the annual fee